Screener
Rigel Pharmaceuticals RIGL Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's net debt / EBITDA?
- Rigel Pharmaceuticals (RIGL) reported net debt / EBITDA of 0.3× in Q1 2026.
- How has Rigel Pharmaceuticals's net debt / EBITDA changed year-over-year?
- Rigel Pharmaceuticals's net debt / EBITDA increased by 136.0% year-over-year, from -1× to 0.3×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Rigel Pharmaceuticals's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude